SCHEMBL7053367

SCHEMBL7053367

O=C(O)c1nccc([N+](=O)[O-])c1Cc1ccccc1

nearest known ligand 0.49

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ASPH Q12797 5/20 0.49
KDM8 Q8N371 5/20 0.49
KDM4E B2RXH2 4/20 0.49
MEN1 O00255 2/20 0.43
KMT2A Q03164 2/20 0.43
RAB9A P51151 3/20 0.41
NPC1 O15118 2/20 0.41
MAPT P10636 1/20 0.41
POLB P06746 2/20 0.40
KCNH2 Q12809 1/20 0.40
CTSB P07858 1/20 0.39
ALDH1A1 P00352 1/20 0.39
GAA P10253 1/20 0.39
SENP8 Q96LD8 1/20 0.39
SENP7 Q9BQF6 1/20 0.39
SENP6 Q9GZR1 1/20 0.39
TDP1 Q9NUW8 1/20 0.39
L3MBTL1 Q9Y468 1/20 0.39
ATM Q13315 1/20 0.39
CYP1A2 P05177 1/20 0.38

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL27467197 0.84 KMT2A (0.42) KDM4EMEN1KMT2ARAB9ANPC1
SCHEMBL7119630 0.77 MEN1 (0.41) KDM4EMEN1KMT2ARAB9ANPC1
SCHEMBL4686653 0.76 TSHR (0.55) KDM4EMEN1KMT2ARAB9AMAPT
SCHEMBL16519973 0.76 TDP1 (0.48) MEN1KMT2ARAB9ANPC1MAPT
SCHEMBL11734394 0.74 KDM4E (0.49) ASPHKDM8KDM4EMEN1KMT2A
SCHEMBL27971912 0.74 KDM4E (0.49) ASPHKDM8KDM4EMEN1KMT2A
SCHEMBL29178118 0.74 KDM4E (0.49) ASPHKDM8KDM4EMEN1KMT2A
SCHEMBL28577900 0.73 KDM4E (0.48) ASPHKDM8KDM4EMEN1KMT2A
SCHEMBL1245681 0.73 TSHR (0.51) ASPHKDM8KDM4EMAPTPOLB
SCHEMBL30380021 0.73 KDM4E (0.48) ASPHKDM8KDM4EMEN1KMT2A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2003026664-A1 2-PHENYLAMINO-4- (5-PYRAZOLYLAMINO) -PYRAMIDINE DERIVATIVES AS KINASE INHIBITORS, IN PARTICULAR, SRC KINASE INHIBITORS BAYER CORPORATION (US) 2003-04-03 WO disclosed